GSK_Annual_Report_2021

Annual Report 2020-21 149 FORM NO. AOC.1 Statement containing salient features of the financial statement of subsidiaries / associate companies / joint ventures (Pursuant To First Proviso To Sub-Section (3) Of Section 129 Read With Rule 5 Of Companies (Accounts) Rules, 2014) Part “A”: Subsidiaries (Information in respect of each subsidiary to be presented with amounts in ` lakhs) 1. Name of the subsidiary : Biddle Sawyer Limited 2. Reporting period for the subsidiary concerned, if different from the holding company’s reporting period : Same Reporting period as of Holding Company 3. Reporting currency and Exchange rate as on the last date of the relevant financial year in the case of foreign subsidiaries : NA 4. Share capital : 96.00 5. Reserves & surplus : 4,68.16 6. Total assets : 46,00.57 7. Total Liabilities : 40,36.41 8. Investments : NIL 9. Turnover : 12,56.22 10. Profit before taxation : 76.22 11. Provision for taxation : 18.24 12. Profit after taxation : 57.98 13. Proposed Dividend : Nil 14. % of shareholding : 100% Notes: The following information shall be furnished at the end of the statement : Not Applicable 1. Names of subsidiaries which are yet to commence operations 2. Names of subsidiaries which have been liquidated or sold during the year. Part “B”: Associates and Joint Ventures Not Applicable